Your browser doesn't support javascript.
loading
Sulfatase modifying factor 1 (SUMF1) is associated with Chronic Obstructive Pulmonary Disease.
Weidner, Julie; Jarenbäck, Linnea; de Jong, Kim; Vonk, Judith M; van den Berge, Maarten; Brandsma, Corry-Anke; Boezen, H Marike; Sin, Don; Bossé, Yohan; Nickle, David; Ankerst, Jaro; Bjermer, Leif; Postma, Dirkje S; Faiz, Alen; Tufvesson, Ellen.
Afiliação
  • Weidner J; Respiratory Medicine and Allergology, Department of Clinical Sciences Lund, BMC, D12, Lund University, Skåne University Hospital, 221 84, Lund, Sweden.
  • Jarenbäck L; Respiratory Medicine and Allergology, Department of Clinical Sciences Lund, BMC, D12, Lund University, Skåne University Hospital, 221 84, Lund, Sweden.
  • de Jong K; University Medical Center Groningen, GRIAC (Groningen Research Institute for Asthma and COPD), Department of Epidemiology, University of Groningen, Groningen, The Netherlands.
  • Vonk JM; University Medical Center Groningen, GRIAC (Groningen Research Institute for Asthma and COPD), Department of Epidemiology, University of Groningen, Groningen, The Netherlands.
  • van den Berge M; University Medical Center Groningen, Department of Pulmonology, GRIAC (Groningen Research Institute for Asthma and COPD), University of Groningen, Groningen, The Netherlands.
  • Brandsma CA; University Medical Center Groningen, Department of Pulmonology, GRIAC (Groningen Research Institute for Asthma and COPD), University of Groningen, Groningen, The Netherlands.
  • Boezen HM; University Medical Center Groningen, GRIAC (Groningen Research Institute for Asthma and COPD), Department of Epidemiology, University of Groningen, Groningen, The Netherlands.
  • Sin D; Department of Medicine (Respirology), University of British Columbia, Centre for Heart Lung Innovation, Vancouver, Canada.
  • Bossé Y; Department of Molecular Medicine, Institut universitaire de cardiologie et de pneumologie de Québec, Laval University, Québec, Canada.
  • Nickle D; Genetics and Pharmacogenomics (GpGx), Merck Research Laboratories, Boston, MA, USA.
  • Ankerst J; Respiratory Medicine and Allergology, Department of Clinical Sciences Lund, BMC, D12, Lund University, Skåne University Hospital, 221 84, Lund, Sweden.
  • Bjermer L; Respiratory Medicine and Allergology, Department of Clinical Sciences Lund, BMC, D12, Lund University, Skåne University Hospital, 221 84, Lund, Sweden.
  • Postma DS; University Medical Center Groningen, Department of Pulmonology, GRIAC (Groningen Research Institute for Asthma and COPD), University of Groningen, Groningen, The Netherlands.
  • Faiz A; University Medical Center Groningen, Department of Pulmonology, GRIAC (Groningen Research Institute for Asthma and COPD), University of Groningen, Groningen, The Netherlands.
  • Tufvesson E; Respiratory Medicine and Allergology, Department of Clinical Sciences Lund, BMC, D12, Lund University, Skåne University Hospital, 221 84, Lund, Sweden. Ellen.Tufvesson@med.lu.se.
Respir Res ; 18(1): 77, 2017 05 02.
Article em En | MEDLINE | ID: mdl-28464818
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sulfatases / Fumar / Polimorfismo de Nucleotídeo Único / Doença Pulmonar Obstrutiva Crônica Tipo de estudo: Diagnostic_studies / Etiology_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male País/Região como assunto: Europa Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sulfatases / Fumar / Polimorfismo de Nucleotídeo Único / Doença Pulmonar Obstrutiva Crônica Tipo de estudo: Diagnostic_studies / Etiology_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male País/Região como assunto: Europa Idioma: En Ano de publicação: 2017 Tipo de documento: Article